RxDoctor Payments DataLook up a doctor →

Keith Atassi, MD

Interventional Cardiology · Valparaiso, INNPI 1336160753

Payments from drug & device makers

$45,322in general payments, 2019–2025

Across 754 payments — averaging $60.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$12K
  • Boehringer Ingelheim$8K
  • Medtronic$4K
  • Boston Scientific$3K
  • Abiomed$3K
  • Novartis$2K
  • plus $13K from 48 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$45,322 in reported general payments places this provider in the 80th percentile of 170 interventional cardiology providers in Indiana.

See all interventional cardiology providers in Indiana

Medicare billing

Part B allowed, 2024
$522,868
Medicare patients
2,074
Services billed
7,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Valparaiso

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →